Work

POSITIVE (IBCSG 48-14/BIG 8-13/A221405): Evaluating outcomes after interrupting endocrine therapy (ET) for women with endocrine responsive (ER+) early breast cancer (BC) who desire pregnancy.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.tps596

Authors: Ann H. Partridge, Olivia Pagani, Hatem A. Azim, Fedro Peccatori, Monica Ruggeri, Meredith M. Regan, Richard D. Gelber, Zhuoxin Sun, for the POSITIVE Steering Commitee

Institutions: Dana-Farber Cancer Institute, Istituto Oncologico della Svizzera Italiana, American University of Beirut, European Institute of Oncology, International Breast Cancer Study Group, Harvard University, Frontier Science & Technology Research Foundation, Inc.

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2806769609

Cites:

Cited by: 5

Related to: 10